Sky TV and F&P lead sharemarket lower
New Zealand shares fell, led lower by Sky Network Television on continued earnings worries, and Fisher & Paykel Healthcare, while Chorus and Arvida Group gained.
The S&P/NZX50 Index dropped 64.15 points, or 0.7 per cent, to 9228. Within the index, 22 stocks fell, 20 rose, and eight were unchanged. Turnover was $137.2 million.
Leading the benchmark index lower was Sky TV, which dropped 3.5 per cent to $2.20. The shares have dropped 17 per cent since the company gave its annual earnings report last month.
“That’s a continuation of a trend we’ve seen since they reported, I would say on concern of continued loss of subscribers, though that’s no great news to anybody,” said Josh Wilson, principal and senior portfolio manager at NZFunds. “The way I looked at it was they’d done a really good job at taking costs out of the business, but there’s only so far you can cut costs and if revenues continue to decline and follow the trend that they have been, then earnings become the meat in the sandwich and will get squeezed.”
Fisher & Paykel Healthcare fell 2.7 per cent to $15.20. On Monday, it warned the cost of contesting the latest patent allegations from rival ResMed will cut annual earnings by as much as $10m in a far-ranging dispute across multiple jurisdictions.
A2 Milk Co fell 3.3 per cent to $12.40 and Auckland International Airport dropped 1.9 per cent to $6.99. Chorus was the best performer, up 2.3 per cent to $4.83, while Arvida Group rose 2.3 per cent to $1.35 and Metlifecare gained 1.9 per cent to $6.40.
NZFunds’ Wilson said much of the focus yesterday had been off-market, with both Steel & Tube Holdings and Oceania Healthcare in trading halts.
Steel & Tube was frozen at $1.23 as it ran a $17.8m shortfall bookbuild following its deeply discounted 1-for1.9 pro rata rights offer, where shareholders bought about $42.3m of new shares at $1.05. Oceania Healthcare was stopped at $1.14 as cornerstone shareholder Macquarie Group began selling down some of its shares. Macquarie intends to sell up to 95 million shares at 79 cents, representing 15.6 per cent of the company, and only part of the 57.2 per cent stake it owns. It means the Macquarie entity will no longer be able to control the appointment of any directors to the board.